Psyence Biomedical (Psyence Biomedical) Price-to-Tangible-Book : (As of May. 14, 2024)

View and export this data going back to 2024. Start your Free Trial

What is Psyence Biomedical Price-to-Tangible-Book?

As of today (2024-05-14), Psyence Biomedical's share price is $0.9649. Psyence Biomedical's Tangible Book per Share of Mar. 2023 for the quarter that ended in Mar. 2023 was $-0.02. Hence, Psyence Biomedical's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Psyence Biomedical's Price-to-Tangible-Book or its related term are showing as below:

PBM's Price-to-Tangible-Book is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.71
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Psyence Biomedical's share price is $0.9649. Psyence Biomedical's Book Value per Sharefor the quarter that ended in Mar. 2023 was $-0.02. Hence, Psyence Biomedical's P/B Ratio of today is .

Psyence Biomedical Price-to-Tangible-Book Historical Data

The historical data trend for Psyence Biomedical's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Biomedical Price-to-Tangible-Book Chart

Psyence Biomedical Annual Data

Trend

Mar21

Mar22

Mar23

Price-to-Tangible-Book

Psyence Biomedical Semi-Annual Data
	Mar21	Mar22	Mar23
Price-to-Tangible-Book	-	-	-

Competitive Comparison of Psyence Biomedical's Price-to-Tangible-Book

For the Biotechnology subindustry, Psyence Biomedical's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Psyence Biomedical's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Psyence Biomedical's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Psyence Biomedical's Price-to-Tangible-Book falls into.

Psyence Biomedical Price-to-Tangible-Book Calculation

Psyence Biomedical's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Mar. 2023 )
	=	0.9649	/	-0.016
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Psyence Biomedical Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Psyence Biomedical's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Psyence Biomedical (Psyence Biomedical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Psyence Biomedical Ltd (NAS:PBM) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

121 Richmond Street West, Penthouse Suite 1300, Toronto, ON, CAN, M5H 2K1

Website

https://www.psyence.com

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Psyence Biomedical (Psyence Biomedical) Headlines

From GuruFocus

Thinking about buying stock in Psyence Biomedical, Micron Technology, Conservative Broadcast Media Journalism, Qualcomm, or Cibus?

By PRNewswire • 02-12-2024